OpenAI submitted a confidential S-1 filing to the SEC on June 8, marking the most consequential step yet in the company’s long-anticipated march toward public markets.

For crypto investors, this isn’t just a Wall Street story. Platforms like OKX and Injective have already launched perpetual futures contracts designed to track OpenAI’s valuation, creating synthetic exposure to a company that doesn’t trade on any exchange yet.

What the confidential filing actually means

A confidential S-1 filing lets a company share its financial details with regulators without immediately exposing them to public scrutiny. The company gets feedback from the SEC, makes revisions, and only goes fully public with its financials closer to the actual listing date.

OpenAI has tapped Goldman Sachs and Morgan Stanley as underwriters, and analysts are speculating that the actual listing could land somewhere between September and November 2026.

The exact valuation from the filing remains undisclosed. Earlier private market estimates placed OpenAI’s worth as high as $1 trillion.

Microsoft, OpenAI’s most prominent backer, has poured billions into the company and integrated its technology across its product suite.

The crypto angle: synthetic exposure and its risks

OpenAI itself has no confirmed involvement with blockchain or cryptocurrency assets.

OKX and Injective have both rolled out perpetual futures contracts tied to OpenAI’s estimated valuation. These instruments let traders go long or short on the company’s perceived worth without touching a single share of actual equity.

These products are synthetic, meaning their pricing relies on market consensus about valuation rather than audited financials or actual share prices. Sharp price drops in related crypto products have followed warnings about invalid share-transfer structures, highlighting the fragility of instruments built on estimated valuations rather than real order books.

The broader IPO wave and what it signals

OpenAI isn’t filing in a vacuum. Anthropic, OpenAI’s most direct competitor in the large language model space, and SpaceX, Elon Musk’s rocket and satellite company, are also reportedly gearing up for IPOs.

What this means for investors

The biggest immediate question for traditional investors is whether OpenAI’s eventual IPO price will reflect the frothy private market valuations or land somewhere more conservative. The gap between a $1 trillion private estimate and whatever the public market ultimately pays will tell us a lot about how AI companies are being priced in 2026.

If both OpenAI and Anthropic go public within months of each other, investors will have the rare opportunity to compare two direct competitors side by side using actual financial data.

As OpenAI’s largest strategic investor, any IPO pricing will directly impact Microsoft’s balance sheet and potentially its stock price.